Finding new treatments for bacterial vaginosis using specific enzymes
Metagenomic discovery and optimization of novel endolysins targeting Gardnerella vaginalis to treat bacterial vaginosis
This study is looking for new ways to treat bacterial vaginosis (BV) by using special enzymes that can kill the bad bacteria without harming the good ones, so women can get better without the side effects of traditional antibiotics.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Topaz Biosciences, INC. NIH-funded |
| Lab location | 1 site (Emeryville, United States) |
| Project ID | NIH-11005378 on NIH RePORTER |
What this research studies
This research focuses on bacterial vaginosis (BV), a common condition affecting women of reproductive age, caused by an imbalance of bacteria in the vagina, particularly involving Gardnerella vaginalis. The project aims to develop novel treatments using endolysins, which are enzymes that can specifically target and destroy harmful bacteria without affecting beneficial ones. By optimizing these endolysins, the research seeks to provide a more effective and less damaging alternative to traditional antibiotic therapies, which often lead to resistance and recurrence of BV. Patients may benefit from a targeted approach that preserves healthy vaginal flora while effectively treating the infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of reproductive age who are experiencing symptoms of bacterial vaginosis.
Not a fit: Patients who do not have bacterial vaginosis or those who are not of reproductive age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for bacterial vaginosis with fewer side effects and lower rates of recurrence.
How similar studies have performed: Other research has shown promise in using endolysins for targeting specific bacteria, indicating potential success for this novel approach.
Where this research is happening
Emeryville, United States
- Topaz Biosciences, INC. — Emeryville, United States (Active)
Researchers
- Principal investigator: Liu, Oliver Wei — Topaz Biosciences, INC.
- Study coordinator: Liu, Oliver Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.